Study to Evaluate the Safety and Pharmacokinetics of CKD-331

NCT05335044 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

47

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypertension and Dyslipidemia

Interventions

DRUG: CKD-331
DRUG: EX5619

Sponsor

Chong Kun Dang Pharmaceutical